Document Detail


APTT reagent with ellagic acid as activator shows adequate lupus anticoagulant sensitivity in comparison to silica-based reagent.
MedLine Citation:
PMID:  22909048     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Background: Lupus anticoagulant (LA) is an antibody that interferes with phospholipids dependent coagulation reactions. Activated partial thromboplastin time (APTT) is widely used as a test for LA screening. APTT reagents are composed of activators, such as silica or ellagic acid, and phospholipids, and APTT reagents with silica are recommended for LA screening because of greater sensitivity. However, the effects of activators on LA activity have not been adequately investigated. Objectives: In this study, we examined whether an ellagic acid-based reagent was highly sensitive to LA in a low phospholipid condition and useful for LA screening. Methods: Silica-based (SL) and ellagic acid-based (EA) reagents were prepared in-house with the same composition and concentration of phospholipids, while the commercial APTT reagents APTT-SLA (SLA), Actin FSL (FSL), APTT-SP (SP), and PTT-LA (PTT) were also included in the study. Results: The normal reference ranges for SL and EA were 30.1-47.0 and 28.0-40.2 seconds, respectively, while the cut-off index values for circulating anticoagulant activity (ICA) calculated from the results obtained with SL, EA, SLA, FSL, SP, and PTT were 12.9, 11.5, 13.2, 15.6, 14.3, and 14.0, respectively. The sensitivity of those reagents based on those cut-off values was 91%, 96%, 68%, 46%, 91%, and 86%, respectively. Conclusions: Our results showed that the ellagic acid-based reagent was more sensitive to LA than silica-based reagents in a low phospholipid condition and had adequate sensitivity to detect LA. We concluded that the sensitivity of APTT reagents for LA is dependent on phospholipid concentration and not the activator.
Authors:
O Kumano; M Ieko; S Naito; M Yoshida; N Takahashi
Related Documents :
12202598 - Are three sputum acid-fast bacillus smears necessary for discontinuing tuberculosis iso...
22901688 - Conjugated linoleic acid suppresses irf3 activation via modulation of cd14.
12172748 - Improved decontamination method for recovering mycobacteria from patients with cystic f...
7320498 - An improved histochemical method for distinguishing colonic acetylsialomucin from other...
6306218 - Studies on the mechanisms of the antisecretory and cytoprotective actions of sch 28080.
3487538 - Timentin and beta-lactamases.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-8-21
Journal Detail:
Title:  Journal of thrombosis and haemostasis : JTH     Volume:  -     ISSN:  1538-7836     ISO Abbreviation:  J. Thromb. Haemost.     Publication Date:  2012 Aug 
Date Detail:
Created Date:  2012-8-22     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101170508     Medline TA:  J Thromb Haemost     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2012 International Society on Thrombosis and Haemostasis.
Affiliation:
Departments of Internal Medicine and University of Hokkaido, Ishikari-Tobetsu, Hokkaido, Japan Departments of Clinical Laboratory, School of Dentistry, Health Sciences University of Hokkaido, Ishikari-Tobetsu, Hokkaido, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Nationwide survey of acromegaly in South Korea.
Next Document:  Over-expression of HSP70 attenuates caspase-dependent and caspase-independent pathways and inhibits ...